Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BPTF | Q12830 | 3/20 | 0.78 |
| ▸ | BRD9 | Q9H8M2 | 3/20 | 0.45 |
| ▸ | BRD4 | O60885 | 2/20 | 0.45 |
| ▸ | BTK | Q06187 | 4/20 | 0.45 |
| ▸ | WEE1 | P30291 | 6/20 | 0.44 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.42 |
| ▸ | AXL | P30530 | 1/20 | 0.41 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.41 |
| ▸ | MERTK | Q12866 | 1/20 | 0.41 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.41 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26910161 | 0.88 | BPTF (1.00) | BPTFBRD9BRD4BTKKAT2B | |
| SCHEMBL26910168 | 0.83 | BPTF (1.00) | BPTFBRD9BRD4BTKKAT2B | |
| SCHEMBL31735865 | 0.75 | BPTF (0.50) | BPTFBRD9BRD4KAT2BDDB1 | |
| SCHEMBL10265028 | 0.74 | BPTF (0.57) | BPTFBTKWEE1DDB1CRBN | |
| SCHEMBL13763484 | 0.72 | BPTF (0.53) | BPTFBTKWEE1 | |
| SCHEMBL26910192 | 0.71 | BPTF (1.00) | BPTFBRD9BRD4KAT2B | |
| SCHEMBL31735413 | 0.71 | BPTF (0.95) | BPTFBRD9BRD4KAT2B | |
| SCHEMBL2583600 | 0.71 | BPTF (0.54) | BPTFBTKWEE1 | |
| SCHEMBL31735885 | 0.71 | BRD4 (0.44) | BPTFBRD9BRD4KAT2B | |
| SCHEMBL31735366 | 0.71 | BRD4 (0.44) | BPTFBRD9BRD4KAT2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025245484-A1 | FOXN1 ACTIVATORS | THYMOFOX INC. (US) | 2025-11-27 | — | — | WO | disclosed |